Navigation Links
Delivering siRNAs to Difficult Cell Types

control siRNA.


Electroporators
Transfection using the siPORT siRNA Electroporation Buffer was performed with two different electro-pulse generators: Gene Pulser Xcell (Bio-Rad) and ECM 830 (BTX). Both electroporators performed approximately equivalently when the same electroporation parameters were used, resulting in equivalent levels of siRNA uptake by several different cell types and similar reduction of gene expression (variability <10%; data not shown). The Gene Pulser Xcell System performed very consistently without sample-to-sample electropulse fluctuations across multiple experiments. The ECM 830 electropulse generator instrument performed with 5-10% sample-to-sample electropulse fluctuations across multiple experiments.


Optimizing siRNA Electroporation Parameters
Experiments revealed that different primary cell types require different electroporation parameters. For example, in a standard 1 mm electroporation cuvette, HUVEC cells require 1 electropulse, 150 S, and 250 Volts; whereas primary NHDF-Neo cells require 2 pulses, 70 S, and 900 Volts. Therefore, as with any transfection, it is important to optimize some critical protocol parameters to ensure maximum delivery of siRNA by electroporation. Transfection efficiency is largely affected by the concentration of siRNA, and can be modulated by varying the siRNA amount within a limited range. To demonstrate the relationship between
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Delivering siRNA Using Adenoviral Vectors
2. Silencer Validated siRNAs
3. Cenix-Designed siRNAs for 95% of Human and Mouse Genomes
4. Five Ways to Produce siRNAs
5. Efficient Delivery of siRNAs to Human Primary Cells: Electroporation vs. Chemical Transfection
6. IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER!
7. Optimizing Chemical Transfection and Electroporation of siRNAs
8. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
9. Deliver siRNAs Into Primary Cells
10. Optimize Transfection of siRNAs for RNAi
11. RNAi as a Tool for Mammalian Gene Analysis: Applications of siRNAs
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Delivering siRNAs Difficult Cell Types

(Date:4/16/2015)... According to the 2014 Liberty Mutual ... was ranked first among the leading causes of ... pushing, pulling, holding, carrying, or throwing and cost ... Round Company takes statistics like this very seriously. ... develop and design equipment that prevents these injuries ...
(Date:4/16/2015)... , April 16, 2015  RegeneRx Biopharmaceuticals, ... announced its U.S. joint venture with G-treeBNT (ReGenTree ... phase 3 clinical trial for the orphan disorder, ... trial for dry eye syndrome (DES) in the ... eye drops, RGN-259/GBT201, this year.  Each of these ...
(Date:4/16/2015)... -- Scientists from Cleave Biosciences will be participating in the ... American Association for Cancer Research Annual Meeting 2015 in ... 19, 2015 from 3:15pm to 5:15pm ET. Daniel ... new in vivo and mechanism of action study results ... critical enzyme that controls various aspects of protein homeostasis. ...
(Date:4/16/2015)... Fairleigh Dickinson University ( FDU ) ... the Executive Director of the Rothman Institute of ... of the Initiative for Patient Centered Innovation (iPCI), ... the Rothman Institute of Innovation and Entrepreneurship (within ... with FDU’s School of Pharmacy’s Center for Healthcare ...
Breaking Biology Technology:The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 2Cleave Biosciences to Participate in Special Session "New Drugs on the Horizon" at AACR Annual Meeting 2015 3Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 2Dr. Joseph V. Gulfo Named Executive Director of Fairleigh Dickinson University’s Rothman Institute to Spearhead New Initiative for Patient-Centered Innovation (iPCI) 3
... June 9 to discuss the prevalence and prevention of NSAID-induced ... - , , BETHESDA, Md. and ... and Horizon Therapeutics, Inc. today launched Connect to Protect ... risks associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs), ...
... week 26 in moderate to severe Crohn,s patients who ... CHICAGO, June 1 New data from the WELCOME ... meeting demonstrate that Cimzia(R) (certolizumab pegol) provides sustained symptom ... patients suffering from moderate to severe Crohn,s disease (CD) ...
... KVISTGAARD, Denmark, June 1 Detailed data from,a ... the,ASCO Annual Meeting in Orlando. The presentation was made by ... and the Dana-Farber Cancer,Institute who is also the principal investigator ... detailed analysis supports the headline data that were reported,in October ...
Cached Biology Technology:AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 2AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use 3Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients 2Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients 3Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients 4Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients 5Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients 6Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients 7Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients 8Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients 9Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients 10PROSTVAC(TM) Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late-Stage Prostate Cancer 2PROSTVAC(TM) Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late-Stage Prostate Cancer 3
(Date:3/19/2015)...  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, announces its biometric payment technology, the Wocket® ... this week on Washington DC,s Fox ... segment "The Next Great Thing", host Laura Evans ... and ,a really big breakthrough in mobile payment.,  ...
(Date:3/17/2015)... March 17, 2015 Emotient, the leader ... today announced general availability of Emotient Analytics ... the analysis of facial expressions. The system analyzes ... content, products and services. It delivers audience response ... sentiment - as derived from facial evidence of ...
(Date:3/12/2015)... -- IriTech, a leading iris based identity management technology ... Design Network, announced today that the Chief Minister ... MK2120U device during a launching event of Andhra Pradesh ... The iris scanner is manufactured by U.S. based ... India through its Indian partner, Biometronic Technology, ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3
... sea areas a serious ecological threat to the ... the environment, e.g. the increase of fish-eating animals ... One of the new guiding principles of political ... "ecosystems approach" should be used instead of traditional ...
... In the work defended at the University of the Basque ... cancer was created in order to reproduce the gene regulation ... as metastasis in the liver of patients. This in vitro ... identification of the origin of the factors regulating this expression, ...
... In the world of commercial materials, lighter and cheaper ... with superior strength and special properties, such as a ... been deformed by a physical or magnetic force. ,A ... has been developed by two research teams headed by ...
Cached Biology News:Fisheries should be regarded as a part of the maritime environment 2It is important to demonstrate the influence of the microenvironment in the process of metastasis 2It is important to demonstrate the influence of the microenvironment in the process of metastasis 3Metal foam has a good memory 2
... cDNA normalization is essential for ... using high-throughput approaches, such as EST ... Most normalization methods are not well ... cDNA. The Evrogen TRIMMER kit, though, ...
... SNP loci identification through targeting resequencing. ... design, intensive assay validation/optimization, high throughput ... or customer-supplied samples and sequence alignment ... for rapid and highly accurate identification ...
... Tissue Extract Protein Array Kit is designed ... extracts. The expression of a protein in ... specific antibody. When the antibody binds the ... sensitive chemiluminescent or fluorescent signal created by ...
... delivers enhanced statistics and statistical interpretation ... improvement managers. As an accepted organizational ... simplifies statistics for novice users and ... experts. It offers a powerful JMP ...
Biology Products: